Yuko Takahashi

Okayama, 7008558, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Journal: Breast cancer (Tokyo, Japan)

Published: September 06, 2026

Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Journal: Breast cancer (Tokyo, Japan)

Published: June 04, 2026

Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study.

Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study.

Journal: Breast cancer (Tokyo, Japan)

Published: March 14, 2026

First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results.

First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results.

Journal: Chinese clinical oncology

Published: December 06, 2025

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study.

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study.

Journal: JCO clinical cancer informatics

Published: September 15, 2025

Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society.

Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society.

Journal: Breast cancer (Tokyo, Japan)

Published: August 13, 2025

Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer.

Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: July 01, 2025

Definitions of, Advances in, and Treatment Strategies for Breast Cancer Oligometastasis.

Definitions of, Advances in, and Treatment Strategies for Breast Cancer Oligometastasis.

Journal: Cancers

Published: May 06, 2025

Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutional study of 1813 cases.

Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutional study of 1813 cases.

Journal: Breast cancer (Tokyo, Japan)

Published: March 01, 2025

Ⅱ. Recurrence Score in Patients with BRCA1/2 Mutation from the OlympiA and TAILORx Trial Results

Ⅱ. Recurrence Score in Patients with BRCA1/2 Mutation from the OlympiA and TAILORx Trial Results

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 25, 2024

Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity.

Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity.

Journal: Breast cancer (Tokyo, Japan)

Published: December 24, 2024

Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness.

Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: September 27, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026